In the 6 types of cancer (bladder cancer, kidney-papillary cell carcinoma, lower grade-glioma, thyroid cancer, liver, and sarcoma), gene set enrichment analysis revealed that PUS7-high subset was enriched for G2/M checkpoint, mitotic spindle, PI3K/AKT/mTOR signaling pathways compared to the PUS7-low subsets. Here, PUS7 is linked to urinary bladder cancer.